79 results, showing 21 to 40
On 10 September 2020, the Australian Competition and Consumer Commission (ACCC) announced it had accepted an undertaking (the Mylan/Upjohn Undertaking) given by Mylan N.V. and its subsidiary Alphapharm Pty Ltd and Upjohn Inc. and its subsidiary Upjohn Australia Pty Ltd pursuant to s 87B of the Competition and Consumer Act 2010 (Cth) in connection with Mylan N.V’s proposed combination with a new entity (Viatris) comprised of Pfizer’s Upjohn Inc. division, including Greenstone LLC (the Proposed Transaction). To support the Mylan/Upjohn Undertaking, the ACCC announced it had also accepted an undertaking given by Pfizer Inc. and Pfizer Australia Pty Ltd pursuant to s 87B of the Competition and Consumer Act 2010 (Cth) in connection with the Proposed Transaction.